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Abstract 
Review on FABP7, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: B-FABP, BLBP, FABPB, MRG 
HGNC (Hugo): FABP7 
Location: 6q22.31 
 
 
Local order: PKIB → FABP7 → SMPDL3A. 
DNA/RNA 
Description 
The FABP7 gene is 4,5 kb long and contains 4 
exons, all of which contain coding sequences. 
The following FABP7 SNPs have been validated: 7 
in the 3' UTR, 6 in the 5' UTR, 5 missense and 4 
SNPs in the coding region that don't alter the amino 
acid code (dbSNP). 
 
 
FABP7 gene. The FABP7 gene is located on chromosome 6 in the region of q22-q23 on the positive strand. Neighboring genes 
are indicated. 
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Crystal structure of FABP7 bound to DHA. The structure of FABP7 is similar to that of other FABPs and consists of two N-
terminal α-helices attached to a β-barrel motif (left). Three amino acids are predicted to be important for fatty acid binding: F104 
(fuchsia), arginine 126 (red) and Y128 (teal) based on the structure of FABP7 bound to DHA. DHA is shown in yellow (right). 
Structural data were obtained from the Protein Data Bank (PDB ID: 1FE3) (Balendiran et al., 2000) and rendered using PyMOL 
(Beaulieu, 2012). 
 
Based on EST data, FABP7 RNA is most highly 
expressed in the fetus, followed by adult brain, eye, 
connective tissue, bone, heart, kidney, mammary 
gland, skin, uterus, lung and testis. 
Transcription regulators: Members of the nuclear 
factor I (NFI) family regulate the transcription of 
the FABP7 gene (Bisgrove et al., 2000; Brun et al., 
2009).  
The phosphorylation state of NFI determines its 
regulatory activity, with FABP7 transcription up-
regulated by hypophosphorylated NFI (Bisgrove et 
al., 2000; Brun et al., 2013). Other transcription 
factors implicated in the regulation of FABP7 
include Notch (Anthony et al., 2005), PAX6 (Arai 
et al., 2005; Numayama-Tsuruta et al., 2010; Liu et 
al., 2012b), and POU-domain protein PBX-1 
(Josephson et al., 1998).  
Furthermore, ligands of peroxisome proliferator-
activated receptors (PPARs) such as clofibrate and 
omega-3 docosahexaenoic acid (DHA) have been 
shown to up-regulate FABP7 expression 
(Nasrollahzadeh et al., 2008; Venkatachalam et al., 
2012). 
Post-transcriptional regulation: The 3' untranslated 
region of FABP7 contains phylogenetically 
conserved cytoplasmic polyadenylation elements 
(CPE) which have been implicated in the trafficking 
and localized translation of FABP7 at perisynaptic 
processes of astrocytic cells (Gerstner et al., 2012). 
Pseudogene 
A predicted FABP7 pseudogene is located on 
chromosome 1 (NCBI nucleotide database 
NG_029025.1). There are two inferred human 
FABP7 pseudogenes listed in the Rat Genome 
Database 
(http://rgd.mcw.edu/rgdweb/report/gene/main.html?
id=5132511 on chromosome 1 and 
http://www.rgd.mcw.edu/rgdweb/report/gene/main.
html?id=6481032 on chromosome 2). 
Protein 
Description 
FABP7 is a member of the intracellular lipid-
binding protein family. FABP7 is a 132 amino acid 
polypeptide with an estimated molecular mass of 15 
kDa.  
It has a beta-clam structure made up of ten anti-
parallel beta sheets capped by two alpha helices. 
Fatty acid ligands reside inside the beta-clam 
structure. 
Expression 
FABP7 is expressed in radial glial cells during 
brain development (Feng et al., 1994). FABP7 
persists in specific regions of the mature mouse 
brain, including glia limitans, in radial glial cells of 
the hippocampal dentate gyrus and Bergman glial 
cells (Kurtz et al., 1994). FABP7 is also expressed 
in glial cells of the peripheral nervous system, and 
ensheathing cells of the olfactory nerve (Kurtz et 
al., 1994). 
Localisation 
The FABP7 protein is found in both the cytoplasm 
and nucleus of normal radial glial cells (Feng et al., 
1994) and tumor cells (Liang et al., 2006; Slipicevic 
et al., 2008). FABP7 is also found in perisynaptic 
processes of astrocytes with localized translation of 
FABP7 at these sites (Gerstner et al., 2012). 
Function 
Recombinant human FABP7 exhibits the highest 
affinity for the polyunsaturated omega-3 fatty acids 
α-linolenic acid, eicosapentaenoic acid, 
docosahexaenoic acid, and for monounsaturated 
omega-9 oleic acid (Kd from 28 to 53 nM) and 
moderate affinity for the polyunsaturated omega-6 
fatty acids, linoleic acid and arachidonic acid (AA) 
(Kd from 115 to 206 nM) (Balendiran et al., 2000).  
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FABP7 has low binding affinity for saturated long 
chain fatty acids. Human FABP7 enhances DHA 
trafficking to the nucleus (Mita et al., 2010). 
FABP7 is required for the establishment of the 
radial glial fiber system along which neurons 
migrate in order to reach their correct destination in 
the developing brain (Feng et al., 1994). FABP7 is 
also required for the maintenance of neuroepithelial 
cells in rat cortex (Arai et al., 2005). FABP7 knock-
out mice have a structurally normal brain; however, 
the mice show enhanced anxiety and increased fear 
memory, as well as decreased DHA in neonatal 
brain and increased AA in adult brain amygdala 
(Owada et al., 2006). 
Homology 
Human FABP7 amino acid sequence is 86,4% 
identical to mouse FABP7, 90,9% identical to 
chicken FABP7, 82,6% identical to zebrafish 
FABP7a and 78% identical to zebrafish FABP7b. 
Human FABP7 shows variable sequence identity 
with the other FABP paralogues, with the lowest 
identity to FABP1 (27,6%) and highest identity to 
FABP3 (65,9%). 
Mutations 
Note 
With the exception of SNPs, no mutations in the 
FABP7 gene have been reported. 
Implicated in 
Malignant glioma (grades III and IV 
astrocytoma) / glioblastoma 
multiforme (grade IV astrocytoma) 
Note 
FABP7 was first reported to be expressed in 
malignant glioma cell lines and malignant glioma 
tumour tissue in 1998 (Godbout et al., 1998). Liang 
et al. (2005) used gene expression profiling to 
demonstrate that FABP7 RNA levels were elevated 
in glioblastoma tumours compared to normal brain. 
These authors showed that elevated levels of 
nuclear FABP7 protein were associated with 
decreased survival in patients with glioblastoma 
multiforme, particularly in younger patients. 
Subsequent analysis of 123 glioblastomas by 
Kaloshi et al. (2007) revealed a correlation between 
nuclear FABP7, EGFR amplification and more 
invasive tumours. De Rosa et al. (2012) also 
showed a correlation between elevated FABP7 
levels and decreased survival in patients with 
glioblastoma multiforme. 
Transfection of a FABP7 expression construct into 
the SF767 malignant glioma cell line results in  
increased cell migration (Liang et al., 2005). A role 
for FABP7 in malignant glioma cell migration was 
confirmed by Mita et al. (2007) who used human 
U87 malignant glioma cell lines stably transfected 
with a FABP7 expression construct to demonstrate 
a correlation between FABP7 expression and 
increased cell migration.  
In agreement with a role for FABP7 in migration 
and infiltration, FABP7 was found to be 
preferentially expressed at sites of infiltration and 
surrounding blood vessels in glioblastoma 
multiforme (Mita et al., 2007). 
Growth of malignant glioma cell lines in the 
presence of polyunsaturated fatty acids omega-3 
DHA and omega-6 AA indicates that the ratio of 
AA:DHA affects migration in FABP7-positive 
cells, with a higher DHA:AA ratio resulting in 
decreased migration (Mita et al., 2010). These 
results suggest that glioblastoma tumour growth 
and infiltration may be controlled by increasing 
levels of DHA in tumour tissue (Elsherbiny et al., 
2013). 
Neurospheres derived from glioblastoma 
multiforme express high levels of FABP7, 
suggesting the presence of FABP7-positive neural 
stem-like cells in glioblastoma (De Rosa et al., 
2012).  
In keeping with this possibility, FABP7 is 
preferentially expressed in the subset of 
glioblastoma tumour cells that express the neural 
stem cell marker CD133 (Liu et al., 2009). Knock-
down of FABP7 in glioblastoma-derived 
neurosphere cultures results in decreased cell 
migration and reduced proliferation (De Rosa et al., 
2012). 
The FABP7 promoter has been shown to be 
hypomethylated in glioblastoma tumours compared 
to normal brain (Etcheverry et al., 2010). 
Breast cancer 
Note 
MRG (mammary-derived growth inhibitor-related 
gene), later shown to be identical to FABP7 
(Hohoff and Spener, 1998), was reported to be 
expressed in normal and benign breast tissue but 
only rarely in breast cancer (1 of 10 infiltrative 
breast cancers and 2 of 12 ductal carcinomas in 
situ) (Shi et al., 1997). Transfection of a MRG 
expression construct into the MDA-MB-231 breast 
cancer cell line suppressed cell proliferation and 
tumour growth in an orthotopic mouse model (Shi 
et al., 1997). Subsequent work showed that MRG 
over-expression induced differentiation in human 
breast cancer cells and that treatment of breast 
cancer cells with DHA causes MRG-dependent 
growth inhibition (Wang et al., 2000).  
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FABP7 mRNA levels are upregulated in human glioblastoma. Comparison of FABP7 mRNA levels in normal human brain 
versus glioblastoma tissues. Database obtained from Oncomine website (www.oncomine.org; Bredel Brain 2). 
 
Preferential expression of FABP7 in estrogen 
receptor-negative breast cancer compared to 
estrogen receptor-positive breast cancer has been 
reported by four separate groups (Tang et al., 2010; 
Zhang et al., 2010; Graham et al., 2011; Liu et al., 
2012a). In an analysis of 176 primary breast 
cancers, Liu et al. (2012) found a correlation 
between elevated FABP7 levels and poor 
prognosis. These authors further showed that 
depletion of FABP7 in FABP7-positive/estrogen-
negative MDA-MB-435S, reduced cell growth and 
sensitized the cells to growth inhibition by DHA. In 
addition, FABP7 was found to mediate DHA-
induced retinoid-X-receptor beta (RXRβ) activation 
in triple-negative BT-20 breast cancer cells as well 
as MDA-MB-435S cells. In a study of 899 invasive 
breast cancer cases, Zhang et al. (2010) showed that 
basal breast cancers (estrogen/progesterone 
receptor-negative, HER2-negative) that were 
FABP7-positive had significantly better outcomes 
than basal breast cancers that were FABP7-
negative. Analysis of the subcellular localization of 
FABP7 in 1249 unselected and 245 estrogen 
receptor-negative invasive breast cancers revealed 
both nuclear and cytoplasmic staining patterns, with 
nuclear FABP7 associated with a high histological 
grade, stage, mitotic frequency, as well as basal and 
triple-negative status (Alshareeda et al., 2012). 
Within the basal category, elevated levels of 
nuclear FABP7 were associated with longer 
disease-free survival. In light of the proposed roles 
for nuclear FABPs in making their fatty acid 
ligands available to nuclear receptors such as 
PPARs, understanding the roles of cytoplasmic and 
nuclear FABP7 will help elucidate its biological 
functions in breast cancer. 
Renal cell carcinoma 
Note 
FABP7 RNA and protein are up-regulated in renal 
cell carcinoma compared to normal kidney tissue 
(Seliger et al., 2005; Teratani et al., 2007; Domoto 
et al., 2007). Analysis of a tissue microarray 
containing 272 renal cell carcinomas showed 
significantly lower levels of FABP7 in grades 3 and 
4 compared to grades 1 and 2 renal cell carcinomas 
(Tölle et al., 2009). No correlation was found 
between patient survival and FABP7 staining 
intensity. In agreement with malignant glioma 
experiments, knock-down of FABP7 in human 
kidney carcinoma cells resulted in decreased cell 
migration (Tölle et al., 2011).  
The regulation of FABP7 in renal cell carcinoma 
has been addressed by analysing the FABP7 
promoter (Takaoka et al., 2011). This analysis 
indicates that BRN2 (POU3F2) and nuclear factor I 
(NFI) may be regulating the expression of FABP7 
in renal cell carcinoma. 
Melanoma 
Note 
FABP7 been reported to be both down-regulated in 
melanoma compared to benign nevi (de Wit et al., 
2005) and widely expressed in melanoma (Goto et 
FABP7 (fatty acid binding protein 7, brain) Godbout R, et al. 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 18(9) 642 
al., 2010). FABP7 immunostaining of 149 primary 
melanomas revealed an association between 
FABP7 expression and tumour thickness, as well as 
a trend towards increased relapse-free survival for 
patients who had tumors with low cytoplasmic 
FABP7 levels (Slipicevic et al., 2008). Knock-
down of FABP7 in human melanoma cells resulted 
in decreased cell proliferation and invasion. There 
was no association between the nuclear expression 
of FABP7 and patient survival in this study 
(Slipicevic et al., 2008).  
Gene expression analysis of 87 primary melanomas 
and 68 metastatic melanoma, combined with 
immunohistochemical analysis of 37 paired primary 
and metastatic melanomas, showed significantly 
decreased FABP7 levels in metastatic melanoma 
compared to primary tumor tissue (Goto et al., 
2010). In metastatic melanoma, FABP7 mRNA 
expression was associated with decreased relapse-
free survival and overall survival (Goto et al., 
2010). Loss of heterozygosity analysis using 
microsatellite markers specific to the FABP7 gene 
revealed that 10 of 20 metastatic melanomas (and 0 
of 14 primary melanomas) had undergone loss of 
one FABP7 allele, leading the authors to postulate 
that genomic instability that favors loss of FABP7 
expression may lead to better prognosis. 
Neurological disorders 
Note 
FABP7 is overexpressed in the brains of Down 
syndrome patients and has been postulated to 
contribute to Down syndrome-associated 
neurological disorders (Sánchez-Font et al., 2003).  
Pelsers et al. (2004) measured FABP7 levels in 
various parts of the adult human brain, with a range 
of 0,8 µg/g wet weight in the striatum and 3,1 µg/g 
in the frontal lobe. Measurement of FABP7 and 
FABP3 levels in the serum of patients with minor 
brain injuries identified both these FABPs as more 
sensitive at detecting brain injury than markers 
currently in use for this purpose. Similarly, serum 
FABP7 and FABP3 served as markers for 
individuals who had undergone ischaemic stroke 
(Wunderlich et al., 2005). FABP7 levels were also 
elevated in the serum of patients with 
neurodegenerative diseases such as Alzheimer's 
disease, Parkinson's disease and other cognitive 
disorders. Although elevated levels of FABP7 were 
found in only one-third of patients, FABP7 is still 
the most discriminatory serum marker identified to 
date (Teunissen et al., 2011). The authors propose 
that elevated levels of FABP7 in serum may reflect 
damage to the central nervous system.  
FABP7-deficient mice have characteristics 
associated with schizophrenia such as decreased 
prepulse inhibition and shortened startle response 
latency (Watanabe et al., 2007). FABP7 RNA 
levels in the postmortem brains of male patients 
with schizophrenia were up-regulated in the 
dorsolateral prefrontal cortex. Furthermore, single 
nucleotide polymorphism (SNP) analysis revealed 
an association between missense polymorphism 
Thr61Met 182C>T) and male patients with 
schizophrenia (Watanabe et al., 2007).  
In a separate study, FABP7 SNPs F704, F705 and 
F709 showed nominal association with bipolar 
disorder (Iwayama et al., 2010). Analysis of 6 
FABP7 variants identified by polymorphic screen 
failed to identify any associations with autism or 
schizophrenia in 285 autistic and 1060 
schizophrenic patients of Japanese descent 
(Maekawa et al., 2010). 
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